Blanchy B G, Coulet P R, Gautheron D C
J Biomed Mater Res. 1986 Apr;20(4):469-79. doi: 10.1002/jbm.820200404.
Factor XIII from placenta was successfully grafted onto collagen membranes by the acyl-azide procedure. The transamidase activity retained on collagen membranes was determined by measuring the increase of fluorescence resulting from dansylcadaverine incorporation into casein. We studied the effect of different factors on the grafting: concentration and composition of the factor XIII preparation in the coupling solution and influence of the preactivation of factor XIII by thrombin. Stability studies have shown that the activity of factor XIII grafted on collagen membranes was almost constant over a period of 8 months. Sterilization by gamma-irradiation of factor XIII revealed a drastic loss of activity while the use of high-energized electron bombardment caused a reduced loss of activity. The potential of such a material for biomedical use is presently under investigation.
通过酰基叠氮法成功地将胎盘来源的凝血因子 XIII 移植到胶原膜上。通过测量丹磺酰尸胺掺入酪蛋白所导致的荧光增加来测定保留在胶原膜上的转酰胺酶活性。我们研究了不同因素对移植的影响:偶联溶液中凝血因子 XIII 制剂的浓度和组成以及凝血酶对凝血因子 XIII 预激活的影响。稳定性研究表明,移植到胶原膜上的凝血因子 XIII 的活性在 8 个月内几乎保持恒定。γ 射线辐照对凝血因子 XIII 进行灭菌显示活性急剧丧失,而使用高能电子轰击导致活性损失减少。目前正在研究这种材料在生物医学领域的应用潜力。